DFX Intelligence
Petrichor Scion Therapeutics LLC
As of · the latest observation of this vehicle; each figure below carries its own filing date
Active deploymentFundraising status unknownADV: Venture Capital Fund
As of · the latest observation of this vehicle; each figure below carries its own filing date
2 additional placement agents
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 15 Mar 2023, Latest Form D filed on 15 Mar 2023: $172M sold, 49 investors. A Form D amount is what was sold at the filing, never a final close.
Drawing the relationship network…
Amounts, each with its basis
- Vintage
- 2022basis: form d first sale
- Target
- unknownnot announced
- First close
- unknownnever inferred from a Form D
- Final close
- unknownonly from an announcement or an LP disclosure
- Announced size
- unknown
- Form D offering
- indefinitewhat may be sold, not what was raised; file 021-430236, sworn by the adviser or filed under this vehicle
- Form D sold
- $172Mas of the filing of Mar 15, 2023, 49 investors
- First sale
- Jan 21, 2022
- Reported GAV
- $296Mon the Form ADV filed Mar 31, 2026; the fund's assets, never its size or dry powder
- Owners (ADV)
- 100
- Reported on ADV
- Mar 31, 2022 to Mar 31, 2026
Fundraising evidence
What counts as raisingA Form D offering is permission to sell, not a fund in market; an amount sold is never a close; an evergreen offering amended every year is not a raise.Unknown
latest Form D 2023-03-15, older than 15 months (fr-1)
evidence dated Mar 15, 2023.
Lifecycle
Active deployment
Lifecycle
vintage 2 to 4 years
age years: 4first sale: Jan 21, 2022vintage year: 2022adv gav as of: Mar 31, 2026vintage basis: Form d first saleform d sold: $172Mform d offering: n/aform d latest filed at: Mar 15, 2023
The fund's own reporting through time
6 Form ADV filings
| Filed | Type | Gross asset value | Owners | Min. investment | Adviser-owned | Audit | |
|---|---|---|---|---|---|---|---|
| Mar 31, 2022 | Venture Capital Fund | $107M | 37 | $5.0M | 0% | yes | |
| Jun 21, 2022 | Venture Capital Fund | $107M | 37 | $5.0M | 0% | yes | |
| Mar 30, 2023 | Venture Capital Fund | $148M | 45 | $5.0M | 0% | yes | |
| Mar 29, 2024 | Venture Capital Fund | $281M | 80 | $5.0M | 0% | yes | |
| Sep 30, 2024 | Venture Capital Fund | $281M | 80 | $5.0M | 0% | yes | |
| Mar 31, 2026 | Venture Capital Fund | $296M | 100 | $5.0M | 0% |
Principals and agents
3 principals on Form D, 0 placement agents
- Aaron W. Kantoff Executive Officer/Promoter
- Tadd Wessel Executive Officer/Promoter
- Samuel W. Hall Executive Officer/Promoter
Service providers
5 named on Form ADV Schedule D and Form D
- AuditorBDO · NEW YORK, New York, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- AdministratorSEI · OAKS, Pennsylvania, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
- CustodianCITY NATIONAL BANK · NEW YORK, New York, United StatesForm ADV filed Mar 31, 2026 reports.adviserinfo.sec.gov
Limited partners and their reported performance
Whose numbers these areEach row is the LP’s own number: its cash flows and its valuation policy as of its reporting date, not the fund’s. Net IRR is printed only when the LP prints one. The vintage is the LP’s definition (CalPERS: year of its first cash flow; WSIB: year of its initial investment).0 public LP reports
No public LP has reported this vehicle. The LP tape is read from public pension disclosures (see Limited partners); a fund appears here only when an LP’s report names it.
Known LPs and allocators
What these amounts and dates areA commitment date prints only when the source printed one; otherwise the row carries the date of the report that listed it. A foundation’s 990-PF line is a holding at fair value on its return, never a commitment.0 relationships, public pensions and the allocator graph, each counted once
No allocator names this vehicle in a public disclosure DFX holds: pension reports, foundation 990-PF returns or endowment disclosures.
Investments attributed to this vehicle
0
No investment attributed to this vehicle. The firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Timeline
4 events
- Mar 31, 2026Auditor changed: BDO replaced Deloitte, first reported on the Form ADV filed March 31, 2026 (previous filing March 31, 2025)Auditor changed Fact Form ADV
- Mar 15, 2023Petrichor Scion Therapeutics LLC filed Form D/A: $172,250,000 sold (indefinite offering), Venture Capital FundForm D filed Fact Form D
- Mar 31, 2022Petrichor Scion Therapeutics LLC first reported on Form ADV by Petrichor Healthcare Capital Management LP (Venture Capital Fund), GAV $106,950,000Fund first reported on Form ADV Fact Form ADV
- Jan 20, 2022Petrichor Scion Therapeutics LLC filed Form D: no sales yet (indefinite offering), Venture Capital FundForm D filed Fact Form D
Evidence
31 observations
Every observation on this vehicle
- Entity type: Limited Liability Company Mar 15, 2023 Fact Form D
- Entity type: Limited Liability Company Jan 20, 2022 Fact Form D
- Form D fund type: Venture Capital Fund Mar 15, 2023 Fact Form D
- Form D fund type: Venture Capital Fund Jan 20, 2022 Fact Form D
- Form D industry group: Pooled Investment Fund Mar 15, 2023 Fact Form D
- Form D industry group: Pooled Investment Fund Jan 20, 2022 Fact Form D
- Amendment: true Mar 15, 2023 Fact Form D
- Amendment: false Jan 20, 2022 Fact Form D
- Revenue range (Form D): Decline to Disclose Mar 15, 2023 Fact Form D
- Revenue range (Form D): Decline to Disclose Jan 20, 2022 Fact Form D
- Incorporated: withinFiveYears Mar 15, 2023 Fact Form D
- Incorporated: withinFiveYears Jan 20, 2022 Fact Form D
- Jurisdiction: Delaware Mar 15, 2023 Fact Form D
- Jurisdiction: Delaware Jan 20, 2022 Fact Form D
- Amount sold (Form D): $172M Mar 15, 2023 Fact Form D
- Amount sold (Form D): $0 Jan 20, 2022 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Mar 15, 2023 Fact Form D
- Exemptions: 06b, 3C, 3C.7 Jan 20, 2022 Fact Form D
- First sale: 2022-01-21 Mar 15, 2023 Fact Form D
- Indefinite offering: true Mar 15, 2023 Fact Form D
- Indefinite offering: true Jan 20, 2022 Fact Form D
- Investors (Form D): 49 Mar 15, 2023 Fact Form D
- Investors (Form D): 0 Jan 20, 2022 Fact Form D
- Minimum investment (Form D): 1 Mar 15, 2023 Fact Form D
- Minimum investment (Form D): 1 Jan 20, 2022 Fact Form D
- Securities offered: pooled Mar 15, 2023 Fact Form D
- Securities offered: pooled Jan 20, 2022 Fact Form D
- Office address: Mar 15, 2023 Fact Form D
- Office address: Jan 20, 2022 Fact Form D
- Year of incorporation: 2021 Mar 15, 2023 Fact Form D
- Year of incorporation: 2021 Jan 20, 2022 Fact Form D
Relationships across DFX
on 1 other DFX graph
Across the graphs
Petrichor Scion Therapeutics LLC is the same institution as 1 record in RIA and Wealth.
RIA and Wealth1
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Record history
3 dated events on the change ledger, latest event first
- Form D filed2023-03-15source on record
- Fund first reported on ADV2022-03-31source on record
- Form D filed2022-01-20source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.